Sintilimab as maintenance treatment for local/regional recurrent esophageal squamous carcinoma after concurrent chemoradiotherapy: a single-arm Ib/II phase study

Sintilimab as maintenance treatment for local/regional recurrent esophageal squamous carcinoma after concurrent chemoradiotherapy: a single-arm Ib/II phase study

BackgroundEsophageal cancer (EC) is an aggressive neoplasm of the gastrointestinal tract that is usually treated with a combination of chemotherapy, radiotherapy (RT), and/or surgery, according to disease status. Despite the availability of multimodal therapeutic strategies, local recurrence is freq...

Full description

Bibliographic Details
Main Authors: Chengxin Liu, Hongfu Sun, Wei Huang, Zhongtang Wang, Chengrui Fu, Dan Han, Qian Zhao, Xue Wu, Baosheng Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Immunology
Subjects:
ESCC
Local/regional recurrent
CCRT
Immunotherapy
Clinical study
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1193394/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1193394/full

Similar Items